• Journal of Innovative Optical Health Sciences
  • Vol. 8, Issue 1, 1540001 (2015)
Ying Ye1, Lai-Xing Wang2, Dan-Ping Zhang1, Yi-Jia Yan1, and Zhi-Long Chen1、*
Author Affiliations
  • 1Department of Pharmaceutical Science & Technology College of Chemistry and Biology, Donghua University Shanghai 201620, P. R. China
  • 2Changhai Hospital, Second Military Medical University Shanghai 200433, P. R. China
  • show less
    DOI: 10.1142/s1793545815400015 Cite this Article
    Ying Ye, Lai-Xing Wang, Dan-Ping Zhang, Yi-Jia Yan, Zhi-Long Chen. Studies on photodynamic mechanism of a novel chlorine derivative (TDPC) and its antitumor effect for photodynamic therapy in vitro and in vivo[J]. Journal of Innovative Optical Health Sciences, 2015, 8(1): 1540001 Copy Citation Text show less
    References

    [1] S. Pervaiz, M. Olivo, "Art and science of photodynamic therapy," Clin. Exp. Pharmacol. Physiol. 33, 551–556 (2006).

    [2] D. E. Dolmans, D. Fukumura, R. K. Jain, "Photodynamic therapy for cancer," Nat. Rev. Cancer 3, 380–387 (2003).

    [3] S. B. Brown, E. A. Brown, I. Walker, "The present and future role of photodynamic therapy in cancer treatment," Lancet Oncol. 5, 497–508 (2004).

    [4] R. K. Pandey, L. N. Goswani, Y. Chen et al., "Nature: A rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy," Laser Surg. Med. 38, 445 (2006).

    [5] J. P. Celli, B. Q. Spring, I. Rizvi et al., "Imaging and photodynamic therapy: Mechanisms, monitoring, and optimization," Chem. Rev. 110, 2795 (2010).

    [6] E. Zenkevich, E. Sagun, V. Knyukshto et al., "Photophysical and photochemical properties of potential porphyrin and chlorin photosensitizers for PDT," J. Photochem. Photobiol. Bio. 33, 171–180 (1996).

    [7] M. Triesscheijn, P. Baas, J. H. Schellens, F. A. Stewart, "Photodynamic therapy in oncology," Oncologist 11, 1034–1044 (2006).

    [8] M. R. Detty, S. L. Gibson, S. J. Wagner, "Current clinical and preclinical photosensitizers for use in photodynamic therapy," J. Med. Chem. 47, 3897– 3915 (2004).

    [9] M. R. Hamblin, J. L. Miller, I. Rizvi, B. Ortel, E. V. Maytin, T. Hasan, "Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer," Cancer Res. 61, 7155–7162 (2001).

    [10] J. Berlanda, T. Kiesslich, V. Engelhardt et al., Comparative in vitro study on the characteristics of different photosensitizers employed in PDT," J. Photochem. Photobiol. Biol. 100, 173–180 (2010).

    [11] R. R. Allison, C. H. Sibata, "Oncologic photodynamic therapy photosensitizers: A clinical review," Photodiagnosis Photodyn. Ther. 7, 61–75 (2010).

    [12] M. Tanaka, H. Kataoka, M. Mabuchi et al., "Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer," Anticancer Res. 31, 763–769 (2011).

    [13] J. S. Friedberg, C. Skema, E. D. Baum et al., "In vitro effects of photodynamic therapy on Aspergillus fumigates," J. Antimicrob. Agents Chemother. 48, 105 (2001).

    [14] Y. Zorlu, F. Dumoulin, M. Durmus, V. Ahsen, "Comparative studies of photophysical and photochemical properties of solketal substituted platinum (II) and zinc(II) phthaloyanine sets," Tetrahedron 66, 3248 (2010).

    [15] S. M. Fien, A. R. Osero , "Photodynamic therapy for non-melanoma skin cancer," J. Natl. Compr. Canc. Netw. JNCCN 5, 531–540 (2007).

    [16] F. Li, K. Na, "Self-assembled Chlorin e6 conjugated chondroitin sulfate nanodrug for photodynamic therapy," Biomacromolecules 12, 1724 (2011).

    [17] T. Mosmann, "Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays," J. Immunol. Methods 65, 55 (2011).

    [18] Y. J. Yan, M. Z. Zheng, Z. L. Chen, X. H. Yu, X. X. Yang, Z. L. Ding, L. Xu, "Studies on preparation and photodynamic mechanism of chlorin P6-13,15- N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo," Bioorg. Med. Chem. 18, 6282–6291 (2010).

    [19] S. Mitra, T. H. Foster, "Carbogen breathing signifi- cantly enhances the penetration of red light in murine tumours in vivo," Phys. Med. Biol. 49, 1891 (2004).

    [20] S. Hatz, J. D. Lambert, P. R. Ogilby, "Measuring the lifetime of singlet oxygen in a single cell: Addressing the issue of cell viability," Photochem. Photobiol. Sci. 6, 1106–1116 (2007).

    [21] J. Moan, K. Berg, "The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen," Photochem. Photobiol. 53, 549– 553 (1991).

    [22] M. Niedre, M. S. Patterson, B. C. Wilson, "Direct near infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo," Photochem. Photobiol. 75, 382–391 (2002).

    [23] S. Hatz, L. Poulsen, P. R. Ogilby, "Time-resolved singlet oxygen phosphorescence measurements from photosensitized experiments in single cells: Effects of oxygen diffusion and oxygen concentration," Photochem. Photobiol. 84, 1284–1290 (2008).

    [24] J. Moan, "On the diffusion length of singlet oxygen in cells and tissues," J. Photochem. Photobiol. B 6, 343–347 (1990).

    [25] D. Bellarosa, M. Binaschi, C. A. Maggi, C. Goso, "Sabarubicin- (MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-kB) activation: Effect of parthenolide on their cytotoxicity," Anticancer Res. 25, 2119 (2005).

    Ying Ye, Lai-Xing Wang, Dan-Ping Zhang, Yi-Jia Yan, Zhi-Long Chen. Studies on photodynamic mechanism of a novel chlorine derivative (TDPC) and its antitumor effect for photodynamic therapy in vitro and in vivo[J]. Journal of Innovative Optical Health Sciences, 2015, 8(1): 1540001
    Download Citation